Arcus Biosciences Inc (RCUS)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 258,000 | 117,000 | 112,000 | 382,882 | 77,517 |
| Property, plant and equipment | US$ in thousands | 47,000 | 51,000 | 35,000 | 32,000 | 10,807 |
| Fixed asset turnover | 5.49 | 2.29 | 3.20 | 11.97 | 7.17 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $258,000K ÷ $47,000K
= 5.49
The fixed asset turnover ratio for Arcus Biosciences Inc has shown fluctuation over the years. In 2020, the company had a high fixed asset turnover ratio of 7.17, indicating that it generated $7.17 in revenue for every dollar invested in fixed assets. This suggests efficient utilization of fixed assets in generating sales.
However, in 2021, the fixed asset turnover ratio increased significantly to 11.97, indicating an even greater efficiency in utilizing fixed assets to generate revenue. This may suggest improvements in operational efficiency or sales growth.
The ratio then decreased in 2022 to 3.20 and further dropped in 2023 to 2.29. These lower ratios suggest a decline in the efficiency of utilizing fixed assets to generate sales during these years, which could be due to various factors such as changes in operating processes, economic conditions, or investments in new assets.
In 2024, there was a slight improvement as the fixed asset turnover ratio increased to 5.49. While an improvement from the previous years, the ratio is still lower compared to the peak in 2021.
Overall, the trend in Arcus Biosciences Inc's fixed asset turnover ratio shows variations in the efficiency of utilizing fixed assets to generate revenue over the years, highlighting the importance of monitoring and analyzing this ratio for insights into the company's operational performance and asset management strategies.
Peer comparison
Dec 31, 2024